Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT04140552
NCT04140552RecruitingNot Applicable

Chinese Research Group of Gallbladder Cancer

Shanghai Jiao Tong University School of Medicine55 sites in 1 country10,000 target enrollmentStarted: January 1, 2008Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
10,000
Locations
55
Primary Endpoint
Overall Survival
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

The Chinese Research Group of Gallbladder Cancer (CRGGC) is a retrospective multicenter registry cohort, collecting electronic medical records of patients diagnosed with gallbladder cancer from hospitals in collaboration.

Detailed Description

The objectives of the CRGGC are as follows:

  1. To study the current diagnosis and treatment of gallbladder cancer in China.
  2. To clarify the prognostic role of debated risk factors associated with gallbladder cancer.
  3. To improve the accurate staging of gallbladder cancer.
  4. To standardize the treatment with gallbladder cancer.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Cross Sectional

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Patients with at least clinical diagnosis of gallbladder cancer, including C23.9 and part of C24.0 (cystic duct cancer).
  • •Patients with accessible electronic medical record

Exclusion Criteria

  • •Patients with undetermined primary site of cancer.

Outcomes

Primary Outcomes

Overall Survival

Time Frame: 5 years

The overall survival data were defined by (date of death) - (date of first diagnosis). The survival status of patients were retrieved from follow-up.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Shanghai Jiao Tong University School of Medicine
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Yingbin Liu, MD, PhD, FACS

Prof.

Shanghai Jiao Tong University School of Medicine

Study Sites (55)

Loading locations...

Similar Trials

Active, not recruiting
Not Applicable
Comprehensive Genomic Profiling Combined With Real Life Data of "The German-Registry of Incidental Gallbladder Carcinoma"Gallbladder Carcinoma
NCT05222854Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest200
Recruiting
Phase 2
Addition of Everolimus to Standard of Care in Carcinoma GallbladderGallbladder Cancer
NCT05833815Banaras Hindu University56
Completed
Not Applicable
A Multicenter Clinical Trial of Stool-based DNA Testing for Early Detection of Colon Cancer in ChinaAdvanced AdenocarcinomaHyperplastic PolypNeoplasmsColorectal CancerColorectal NeoplasmsDigestive System Neoplasm
NCT04722055Creative Biosciences (Guangzhou) Co., Ltd.1,273
Unknown
Phase 1
JS001 Combined With Regorafenib in Patients With Advanced Colorectal CancerColorectal Cancer
NCT03946917Sun Yat-sen University44
Recruiting
Not Applicable
China Liver Cancer Clinical Registry Cohort Database (HEAL)Liver Cancer
NCT06777485Anhui Provincial Hospital10,000